General Information of Drug (ID: DM7YAE0)

Drug Name
kallstroemin D Drug Info
Synonyms kallstroemin D
Indication
Disease Entry ICD 11 Status REF
Discovery agent N.A. Investigative [1]
Cross-matching ID
PubChem CID
73754998
TTD Drug ID
DM7YAE0

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DTT
Drug Status:
Discontinued Drug(s)
Preclinical Drug(s)
Investigative Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
T487 DMZTL7H Psoriatic disorder EA90 Discontinued in Phase 2 [3]
JT07 DMHBWOP Solid tumour/cancer 2A00-2F9Z Preclinical [4]
dioscin DM5H2W9 Hepatic fibrosis DB93.0 Preclinical [2]
NBI-74330 DMURC6X Discovery agent N.A. Investigative [3]
Sch-900875 DM346KA Inflammation 1A00-CA43.1 Investigative [5]
hypoglaucin A DMJKIUX Discovery agent N.A. Investigative [2]
⏷ Show the Full List of 6 Drug(s)

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
C-X-C chemokine receptor type 3 (CXCR3) TT1UCIJ CXCR3_HUMAN Antagonist [2]

References

1 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 843).
2 Discovery of structurally diverse natural product antagonists of chemokine receptor CXCR3. Mol Divers. 2005;9(1-3):123-9.
3 Pharmacological characterization of CXC chemokine receptor 3 ligands and a small molecule antagonist. J Pharmacol Exp Ther. 2005 Jun;313(3):1263-71.
4 Clinical pipeline report, company report or official report of Jyant Technologies.
5 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Target id: 70).